Temperature, light and moisture
Exposure may change the active substance, excipients, container or the rate at which degradation occurs.
Product evidence note · O-042
Storage, transport and degradation claims
A storage claim needs evidence for the exact substance, formulation and container. A certificate measured at one time point cannot reconstruct unknown transport or predict a shelf life.
Storage and transport can change a peptide product, but the effect depends on the molecule, formulation, container, temperature, light, moisture, agitation and time. Without product-specific stability data, neither a generic storage rule nor a one-off certificate can establish that a vial remained within specification.
What can change during storage and transport
Different stressors can lead to different failures.
Agitation and freeze-thaw
Some formulations may aggregate, adsorb to surfaces or change physically. The effect cannot be generalised across products.
Progressive change
A sample can meet a result on day one and fail later. A shelf life needs repeated measurements under defined conditions.
Closure and compatibility
Seal integrity, oxygen, leachables, adsorption and contamination controls can be part of the product-specific assessment.
A certificate describes a sample at a test date
A certificate can report what selected tests found in the submitted sample. It does not prove the history of every vial carrying the same batch label, and it does not show what happened after sampling.
If transport temperature, packaging, delays and custody were not recorded, the certificate cannot fill those gaps. It also cannot support an expiry date unless the relevant stability programme, specifications and time points exist.
Use what the certificate actually described, then check the sample handling and chain of custody.
What credible stability evidence looks like
A stability programme defines the exact product, container, storage conditions, time points, specifications and methods before interpreting results. It uses methods capable of distinguishing the active substance from relevant degradation products.
Accelerated or stress studies can reveal degradation pathways and support development, but they do not automatically replace real-time data. A study on a different sequence, concentration, excipient, container or physical form cannot be copied across without justification.
Questions for a storage claim
A credible claim should survive all six.
- Which exact product was studied?Match molecule, formulation, strength, physical form and container.
- Which conditions were controlled?Look for temperature, humidity, light, orientation and relevant transport stresses.
- Which time points were measured?A baseline alone is not a stability curve.
- Which attributes were tested?Identity, assay, impurities, physical change and microbiology may need different methods.
- Were methods stability-indicating?The method must distinguish the target from relevant degradants.
- Does the claim match the data?Do not extend beyond the studied condition, duration or product.
Source ledger
Primary guidance and standards checked on 8 August 2026.
- ICH Q1A(R2): Stability testing · Stability needs product-specific data across time and defined environmental conditions.
- ICH Q2(R2): Validation of analytical procedures · A method must be suitable for its intended purpose; identity, assay, impurities and other measurements have distinct performance requirements.
- UKAS laboratory accreditation · ISO/IEC 17025 accreditation concerns competence for specified testing; the accredited schedule still needs checking.
Follow the adjacent evidence
Certificate readingWhat the certificate actually describedSeparate the sample and test date from later handling.
Testing boundaryWhat peptide tests can and cannot proveMatch every result to one measured attribute.
Sample integritySample handling and chain of custodyCheck whether the tested sample represents the vial in question.
Questions people ask
Does refrigeration prove a peptide remains stable?
No. Refrigeration is a condition, not a result. Stability depends on the exact molecule, formulation, container, temperature range, time and measured attributes. Product-specific data are needed.
Can heat or freezing damage a peptide product?
They can affect some products, but the direction and size of the effect are formulation-specific. A temperature excursion cannot be judged reliably from a generic peptide rule.
Does a COA prove the vial survived delivery?
No. A certificate reports selected findings for the sample and date it covers. It cannot establish later transport conditions, custody, container integrity or the condition of every vial.
What is a stability-indicating method?
It is an analytical method shown to measure the intended attribute while distinguishing relevant degradation products or interferences. Suitability depends on the method’s stated purpose and validation.
Can an accelerated study set a shelf life?
Accelerated data can support development and reveal degradation, but they do not automatically replace the real-time, product-specific evidence needed for a defensible shelf-life claim.
Does clear appearance mean a peptide is unchanged?
No. Visual inspection may find particles, colour or container problems, but chemical degradation or an incorrect amount can be invisible. Appearance cannot replace suitable testing.
Editorial experience
From our work: how we checked this page
For topical-map item O-042, Storage, transport and degradation claims was checked as a distinct editorial task, not treated as a generic peptide page. We reviewed 3 unique external sources and 6 internal destinations in the page, then checked that the opening answer, headings, source descriptions and linked next steps stayed within the same claim boundary. The count records links in the published page and is not a claim that every source carries equal evidential weight.
Eleni Kiromitis checked study design, biomedical evidence, evidence directness and laboratory context. Dr Stavroula Nikitopoulou checked clinical claims, adverse effects, contraindications, red flags and patient-facing safety wording. Each reviewer stayed within the remit published on the governance page. Yianni Kiromitis retained responsibility for source verification, editorial decisions and correction management.
We did not use patient experience, a personal treatment outcome, seller testimony or an assumed product identity to support this page. The publication did not independently test a vial for this review. Where a page refers to a laboratory result, that result applies only to the named sample, method and attribute. We kept uncertainty beside the conclusion, recorded which source supports each material claim, and checked that the visible review date matches the publication record. A new controlled study, regulator update, corrected source, analytical report or credible safety signal can trigger reassessment through the public correction route.